Cerner (NASDAQ:CERN) had its price objective boosted by Royal Bank of Canada from $67.00 to $71.00 in a research report issued on Thursday, Marketbeat.com reports. The brokerage presently has a “buy” rating on the stock. Royal Bank of Canada’s price objective would indicate a potential upside of 18.45% from the company’s previous close.

Other equities analysts have also issued reports about the company. SunTrust Banks cut their price objective on Cerner from $68.00 to $2.82 and set a “hold” rating on the stock in a research note on Wednesday, February 7th. Cantor Fitzgerald cut their price objective on Cerner from $83.00 to $80.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 7th. Argus lowered Cerner from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $54.49 to $64.65 in a research note on Tuesday, March 13th. BidaskClub lowered Cerner from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 15th. Finally, Canaccord Genuity dropped their price target on Cerner from $73.00 to $64.00 and set a “buy” rating on the stock in a research note on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $68.74.

Cerner stock opened at $59.94 on Thursday. The company has a current ratio of 2.95, a quick ratio of 2.93 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $19.72 billion, a P/E ratio of 27.25, a P/E/G ratio of 1.87 and a beta of 0.96. Cerner has a one year low of $52.05 and a one year high of $73.86.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Wednesday, May 2nd. The company reported $0.58 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.58. The company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.34 billion. Cerner had a return on equity of 15.80% and a net margin of 16.50%. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.59 earnings per share. equities analysts predict that Cerner will post 2.28 earnings per share for the current fiscal year.

In other news, Vice Chairman Clifford W. Illig sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The stock was sold at an average price of $58.32, for a total transaction of $174,960.00. Following the transaction, the insider now directly owns 1,229,719 shares of the company’s stock, valued at $71,717,212.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the company’s stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $64.52, for a total value of $19,852,804.00. Following the transaction, the insider now directly owns 1,229,719 shares in the company, valued at $79,341,469.88. The disclosure for this sale can be found here. Insiders have sold 327,948 shares of company stock worth $21,083,917 over the last ninety days. 4.71% of the stock is owned by insiders.

Large investors have recently modified their holdings of the company. Icon Wealth Partners LLC acquired a new position in shares of Cerner during the fourth quarter worth approximately $107,000. MV Capital Management Inc. acquired a new position in shares of Cerner during the first quarter worth approximately $116,000. Cerebellum GP LLC acquired a new position in shares of Cerner during the fourth quarter worth approximately $127,000. Delpha Capital Management LLC acquired a new position in shares of Cerner during the fourth quarter worth approximately $144,000. Finally, Archford Capital Strategies LLC acquired a new position in shares of Cerner during the first quarter worth approximately $181,000. 79.30% of the stock is currently owned by institutional investors.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.